Pfizer anticipates having initial results of the Phase 2/3 vaccine trials in September for the 5- to 11-year-old group, with results for kids of 2 and 5 after that.
nowtheendbegins.com
Pfizer anticipates having initial results of the Phase 2/3 vaccine trials in September for the 5- to 11-year-old group, with results for kids of 2 and 5 after that.
nowtheendbegins.com